SIMA Urges Tamil Nadu CM to Address Critical Power Issues Affecting Textile Mills IRIDEX Corporation IRIX Delivers Q1 2026 Beat EPS 003 vs 007 Expected White House Touts Soybean and Rare Earth Deals After TrumpXi Summit China Highlights Tariff Cuts Paul Tudor Jones Sees No Chance of Fed Rate Cuts Under Potential Warsh Leadership Barclays Upgrades CocaCola Price Target to 89 Reaffirms Overweight Rating Ledn Projects 1 Trillion Potential Market for BitcoinBacked Loans US Job Growth Surges to MultiYear High Fueled by Healthcare Sector Hiring Qualcomm Stocks LongTerm Outlook What Could Shape Its Value by 2028 Ral Castro Indictment Sparks Mixed Reactions Among CubanAmerican Community Geopolitical Tensions Could Affect CubaRelated Investments Kevin Warsh Appointed Fed Chair Pledges ReformOriented Agenda in SwearingIn Ceremony Stem Inc Q1 2026 Earnings EPS Surprises to the Upside as Stock Rises DXR Q3 2007 Earnings Stunning Earnings Beat Driven by NonOperating Income HUMA Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Gain GNPX Q1 2026 Earnings ClinicalStage Biotech Reports Net Loss with No Revenue Stock Moves Up 074 ConocoPhillips Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Lower Regency Centers Preferred REGCO Gains 14 as Preferred Shares Find Their Footing Pliant Therapeutics PLRX Faces Selling Pressure Testing Key Support at 115 Vine Hill Capital II Units VHCPU Edge Higher in Quiet Trading VSE Corporation Tangible Equity Units VSECU Holds Steady at 4653 Amid Consolidation Bolt Biotherapeutics BOLT Slips 12 as Shares Test Key Support at 465 SmartKem Inc SMTK Declines Sharply Testing Key Support at 025 Equity Lifestyle Properties ELS Declines Support Levels Under Scrutiny After 172 Drop Verastem VSTM Slips Slightly Navigating Support and Resistance at 424 Belden Inc BDC Edges Higher Testing Resistance Zone Churchill Downs CHDN Faces Headwinds Stock Dips 316 Amid Volume Concerns Ecovyst Inc ECVT Edges Higher Testing Resistance After a Modest Gain Restaurant Adopts PayWhatYouWant Model as Diners Stay Home AIN Q1 2026 Earnings Significant EPS Beat Driven by Operational Strength Esperion Therapeutics ESPR Holds Steady Amid Key Support and Resistance Levels